Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.18 USD | -0.08% | -5.29% | +12.09% |
13/05 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
10/05 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.09% | 164.62Cr | |
+7.75% | 11TCr | |
+10.35% | 11TCr | |
+0.41% | 2.23TCr | |
-11.94% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-5.53% | 1.72TCr | |
+7.08% | 1.43TCr | |
+36.12% | 1.25TCr |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Piper Sandler Starts Soleno Therapeutics With Overweight Rating, $93 Price Target